Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Senna leaf contains anthraquinone glycosides—primarily sennosides A and B—which are metabolized by colonic bacteria into rheinanthrone, stimulating intestinal peristalsis and electrolyte secretion to produce a reliable laxative effect. A randomized, placebo-controlled trial (PMID 32969946) demonstrated that senna significantly improved stool frequency and consistency versus placebo in chronic constipation, and the 2023 AGA-ACG Clinical Practice Guideline (PMID 37211380) conditionally recommends senna as a stimulant laxative for chronic idiopathic constipation.
Reported Benefits (Provisional)
Origin & History
Senna Leaf (Senna alexandrina) is native to North Africa, the Indian Subcontinent, and the Middle East, thriving in arid and semi-arid regions. Historically revered in Traditional Arabic, Greek, and Ayurvedic medicine, it is primarily valued in functional nutrition for its potent laxative and detoxifying properties.
Research Narrative (Provisional)
A 2021 randomized, placebo-controlled trial by Morishita et al. in the American Journal of Gastroenterology (PMID 32969946) found that senna significantly improved stool frequency, stool consistency (assessed via the Bristol Stool Form Scale, PMID 9299672), and constipation symptoms compared to placebo over a 4-week period in patients with chronic constipation. The 2023 AGA-ACG Clinical Practice Guideline published simultaneously in Gastroenterology (PMID 37211380) and the American Journal of Gastroenterology (PMID 37204227) conditionally recommends stimulant laxatives including senna for chronic idiopathic constipation when osmotic laxatives are insufficient. An updated 2021 systematic review by Rao et al. in the American Journal of Gastroenterology (PMID 33767108) confirmed the efficacy and acceptable short-term safety profile of over-the-counter stimulant laxatives, including senna, for chronic constipation. A Cochrane systematic review (PMID 27531591) also supports senna's use in pediatric constipation management, finding it effective alongside osmotic laxatives.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber - Vitamins: C, E (trace amounts) - Minerals: Calcium, Magnesium, Potassium - Phytochemicals: Anthraquinone Glycosides (Sennosides A and B), Flavonoids (Kaempferol, Quercetin), Phenolic Acids, Resins, Mucilage
Reported Mechanism (Provisional)
Senna leaf's primary active constituents, sennosides A and B (dianthrone glycosides), pass unabsorbed through the upper gastrointestinal tract and are hydrolyzed by colonic bacterial β-glucosidases to yield the active aglycone rheinanthrone. Rheinanthrone directly stimulates submucosal sensory neurons and myenteric plexus activity, upregulates cyclooxygenase-2 (COX-2) expression in intestinal macrophages, and increases prostaglandin E2 (PGE2) production, collectively enhancing propulsive peristaltic contractions. Simultaneously, rheinanthrone inhibits Na⁺/K⁺-ATPase on colonocyte membranes and opens chloride channels, increasing luminal water and electrolyte secretion—thereby softening stool and accelerating colonic transit. Additional minor bioactives including flavonoids (e.g., kaempferol derivatives) identified in Senna species (PMID 19446609) contribute modest antioxidant and anti-inflammatory activity in intestinal tissues.
Clinical Narrative (Provisional)
Clinical evidence is predominantly preclinical, with animal studies showing antioxidant activity (DPPH IC₅₀: 206.01 µg/mL) and metabolic benefits in streptozotocin-induced diabetic rats. Toxicology studies established an LD₅₀ of 5000 mg/kg in rats with no toxicity at therapeutic doses (20 mg/kg rats, 500 mg/kg dogs). Human clinical trial data remains limited in current literature. Short-term efficacy for constipation is well-established, but robust randomized controlled trials are needed.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.